| 摘要 |
The present invention refers to arylalkyldiazinones of formula I: wherein R1, R2, R3, R4, B, Q, and X represent as indicated in claim 1, and to the acceptable salts thereof. The invention further refers to a process for the preparation of said compounds, to pharmaceutical preparations containing them and to the use thereof for the treatment of inflammatory conditions, such as allergies, asthma and self-immunodeficiencies. The novel compounds of the present invention have a phosphodiesterase IV inhibiting action.
|
